Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no substantive changes to trial details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T05:40:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The Publications section was updated: a sentence about voluntarily provided publications (revision 3.3.1) was added, and the previous sentence about study results (revision 3.2.0) was removed.
    Difference
    0.1%
    Check dated 2025-11-23T08:11:16.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removal of the government funding status banner. This does not change the study details, eligibility criteria, or enrollment information shown on the page.
    Difference
    0.3%
    Check dated 2025-11-16T06:05:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    No significant changes detected in the study record NCT04131543; the screenshots show the same study details with minor formatting changes and potentially updated timestamps. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-02T00:36:30.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Key update: page now warns about potential delays due to funding lapses and confirms the NIH Clinical Center is open, plus a version upgrade to v3.2.0.
    Difference
    2%
    Check dated 2025-10-04T11:32:03.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Adds multiple contact emails and phone numbers and updates the revision from v3.0.2 to v3.1.0; core content and key identifiers are unchanged beyond the version bump.
    Difference
    0.0%
    Check dated 2025-09-27T07:34:12.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.